240 related articles for article (PubMed ID: 24185704)
1. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron.
Echeverria GV; Cooper TA
Nucleic Acids Res; 2014 Feb; 42(3):1893-903. PubMed ID: 24185704
[TBL] [Abstract][Full Text] [Related]
2. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.
Warf MB; Diegel JV; von Hippel PH; Berglund JA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9203-8. PubMed ID: 19470458
[TBL] [Abstract][Full Text] [Related]
3. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.
Sen S; Talukdar I; Liu Y; Tam J; Reddy S; Webster NJ
J Biol Chem; 2010 Aug; 285(33):25426-37. PubMed ID: 20519504
[TBL] [Abstract][Full Text] [Related]
4. An intron enhancer recognized by splicing factors activates polyadenylation.
Lou H; Gagel RF; Berget SM
Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
[TBL] [Abstract][Full Text] [Related]
5. Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.
Gates DP; Coonrod LA; Berglund JA
J Biol Chem; 2011 Sep; 286(39):34224-33. PubMed ID: 21832083
[TBL] [Abstract][Full Text] [Related]
6. The U1 small nuclear ribonucleoprotein/5' splice site interaction affects U2AF65 binding to the downstream 3' splice site.
Côté J; Beaudoin J; Tacke R; Chabot B
J Biol Chem; 1995 Feb; 270(8):4031-6. PubMed ID: 7876151
[TBL] [Abstract][Full Text] [Related]
7. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition.
Izquierdo JM
J Biol Chem; 2008 Jul; 283(27):19077-84. PubMed ID: 18463097
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for U2AF to define 3' splice sites and regulate alternative splicing in the human genome.
Shao C; Yang B; Wu T; Huang J; Tang P; Zhou Y; Zhou J; Qiu J; Jiang L; Li H; Chen G; Sun H; Zhang Y; Denise A; Zhang DE; Fu XD
Nat Struct Mol Biol; 2014 Nov; 21(11):997-1005. PubMed ID: 25326705
[TBL] [Abstract][Full Text] [Related]
9. Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.
Huang SC; Zhang HS; Yu B; McMahon E; Nguyen DT; Yu FH; Ou AC; Ou JP; Benz EJ
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28193846
[TBL] [Abstract][Full Text] [Related]
10. Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.
Sharma S; Falick AM; Black DL
Mol Cell; 2005 Aug; 19(4):485-96. PubMed ID: 16109373
[TBL] [Abstract][Full Text] [Related]
11. Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions.
Thanaraj TA; Clark F
Nucleic Acids Res; 2001 Jun; 29(12):2581-93. PubMed ID: 11410667
[TBL] [Abstract][Full Text] [Related]
12. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
[TBL] [Abstract][Full Text] [Related]
13. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.
Grammatikakis I; Goo YH; Echeverria GV; Cooper TA
Nucleic Acids Res; 2011 Apr; 39(7):2769-80. PubMed ID: 21109529
[TBL] [Abstract][Full Text] [Related]
14. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.
Tran H; Gourrier N; Lemercier-Neuillet C; Dhaenens CM; Vautrin A; Fernandez-Gomez FJ; Arandel L; Carpentier C; Obriot H; Eddarkaoui S; Delattre L; Van Brussels E; Holt I; Morris GE; Sablonnière B; Buée L; Charlet-Berguerand N; Schraen-Maschke S; Furling D; Behm-Ansmant I; Branlant C; Caillet-Boudin ML; Sergeant N
J Biol Chem; 2011 May; 286(18):16435-46. PubMed ID: 21454535
[TBL] [Abstract][Full Text] [Related]
15. A targeted oligonucleotide enhancer of SMN2 exon 7 splicing forms competing quadruplex and protein complexes in functional conditions.
Smith LD; Dickinson RL; Lucas CM; Cousins A; Malygin AA; Weldon C; Perrett AJ; Bottrill AR; Searle MS; Burley GA; Eperon IC
Cell Rep; 2014 Oct; 9(1):193-205. PubMed ID: 25263560
[TBL] [Abstract][Full Text] [Related]
16. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.
Goers ES; Purcell J; Voelker RB; Gates DP; Berglund JA
Nucleic Acids Res; 2010 Apr; 38(7):2467-84. PubMed ID: 20071745
[TBL] [Abstract][Full Text] [Related]
17. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
18. YB-1 binds to CAUC motifs and stimulates exon inclusion by enhancing the recruitment of U2AF to weak polypyrimidine tracts.
Wei WJ; Mu SR; Heiner M; Fu X; Cao LJ; Gong XF; Bindereif A; Hui J
Nucleic Acids Res; 2012 Sep; 40(17):8622-36. PubMed ID: 22730292
[TBL] [Abstract][Full Text] [Related]
19. Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.
Soares LM; Zanier K; Mackereth C; Sattler M; Valcárcel J
Science; 2006 Jun; 312(5782):1961-5. PubMed ID: 16809543
[TBL] [Abstract][Full Text] [Related]
20. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition.
Heiner M; Hui J; Schreiner S; Hung LH; Bindereif A
RNA Biol; 2010; 7(1):56-64. PubMed ID: 19946215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
